Orchard Therapeutics plc
SEC CIK 1748907 · ORTX · last insider filing 2024-01-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Geraghty James A | Director | filed 2020 - 2024 |
| Rowland Charles A Jr | Director | filed 2020 - 2024 |
| Altschuler Steven | Director | filed 2020 - 2024 |
| Curnutte John T | Director | filed 2020 - 2024 |
| Secor Alicia | Director | filed 2020 - 2024 |
| Beck Joanne T. | Director | filed 2020 - 2024 |
| Dunoyer Marc | Director | filed 2020 - 2024 |
| Gaspar Bobby | Director · See Remarks | filed 2020 - 2024 |
| RA Capital Healthcare Fund LP | Director | filed 2020 - 2021 |
| RA Capital Management, LLC | Director | filed 2020 - 2021 |
| Kolchinsky Peter | Director | filed 2020 - 2021 |
| Shah Rajeev M. | Director | filed 2020 - 2021 |
| GSK plc | Director | filed 2020 - 2020 |
| Rothera Mark | Director · See Remarks | filed 2020 - 2020 |
| Ellis Jon | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thomas Frank E | See Remarks | filed 2020 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.